跳至主要内容
临床试验/NCT06404164
NCT06404164招募中不适用

Artificial Intelligence Pulmonary Watershed Terrain Navigation System for Lung Nodule Localization and Lung Function Preservation

Guangdong Provincial People's Hospital1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2022年1月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
3,000
试验地点
1
主要终点
Lung fuction

研究概览

简要总结

A method of ICG counterstaining localization under target artery occlusion without cutting,It's a new method of localization of small pulmonary nodules.

详细描述

  1. This technology can replace part of CT puncture-guided positioning, which not only saves CT positioning costs for patients, but also saves time and space resources in CT room;
  2. The target artery occlusion technique does not cut off the blood vessels, and the operation is still a wedge resection. Compared with the standard segmentectomy/subsegmentectomy, the steps of cutting off the veins and bronchial tubes are reduced, the operation time is shortened, and the turnover rate is improved.
  3. There is less damage to the lung tissue, and the lung function is well preserved. The patients can be discharged in an average of 3 days after the operation, which improves the bed turnover efficiency of the department.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • <1cm CTR≤0.75; <1.5cm CTR≤0.5; <2cm CTR≤0.25 Lung nodules
  • The tumor center is located in the peripheral 2/3 area of the lung field
  • Preoperative analysis and planning of watershed by 3D reconstruction
  • Clinically assessed as cT1aN0M0 stage IA1/cT1bN0M0 stage IA2 (eighth edition), clinically resectable

排除标准

  • No surgical video, no postoperative gross specimen and related distance measurement records
  • The incision edge does not exceed the target nodule diameter from the nodule edge
  • The resection range exceeds 50% of the preoperative planning
  • Postoperative pathological staging non-pT1aN0M0 IA1 stage/pT1bN0M0 IA2 stage (eighth edition)
  • Any situation where the investigator feels the need for extended resection
  • Patients with chronic diseases (such as COPD, pulmonary fibrosis, silicosis) that can cause loss of lung function in patients at risk of progression or potential progression

结局指标

主要结局

Lung fuction

时间窗: 1month 3month 1year

testing FEV1 and FVC with MIR Spirolab

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wen-zhao ZHONG

Director

Guangdong Provincial People's Hospital

研究点 (1)

Loading locations...

相似试验